These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30142207)

  • 21. Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice.
    Liang H; Yang R; Liu Z; Li M; Liu H; Jin X
    PLoS One; 2018; 13(3):e0194860. PubMed ID: 29590178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yellow fever vaccine protects mice against Zika virus infection.
    Vicente Santos AC; Guedes-da-Silva FH; Dumard CH; Ferreira VNS; da Costa IPS; Machado RA; Barros-Aragão FGQ; Neris RLS; Dos-Santos JS; Assunção-Miranda I; Figueiredo CP; Dias AA; Gomes AMO; de Matos Guedes HL; Oliveira AC; Silva JL
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009907. PubMed ID: 34735450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
    Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
    Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zika virus baculovirus-expressed envelope protein elicited humoral and cellular immunity in immunocompetent mice.
    Shin M; Kim K; Lee HJ; Lee R; Jung YJ; Park J; Hahn TW
    Sci Rep; 2022 Jan; 12(1):660. PubMed ID: 35027643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zika Virus Mucosal Infection Provides Protective Immunity.
    Martínez LE; Garcia G; Contreras D; Gong D; Sun R; Arumugaswami V
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain.
    Nazerai L; Buus S; Stryhn A; Thomsen AR; Christensen JP
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
    Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid development of a DNA vaccine for Zika virus.
    Dowd KA; Ko SY; Morabito KM; Yang ES; Pelc RS; DeMaso CR; Castilho LR; Abbink P; Boyd M; Nityanandam R; Gordon DN; Gallagher JR; Chen X; Todd JP; Tsybovsky Y; Harris A; Huang YS; Higgs S; Vanlandingham DL; Andersen H; Lewis MG; De La Barrera R; Eckels KH; Jarman RG; Nason MC; Barouch DH; Roederer M; Kong WP; Mascola JR; Pierson TC; Graham BS
    Science; 2016 Oct; 354(6309):237-240. PubMed ID: 27708058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection.
    Hassert M; Wolf KJ; Schwetye KE; DiPaolo RJ; Brien JD; Pinto AK
    PLoS Pathog; 2018 Sep; 14(9):e1007237. PubMed ID: 30212537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine.
    Bullard BL; Corder BN; Gorman MJ; Diamond MS; Weaver EA
    Sci Rep; 2018 Dec; 8(1):18017. PubMed ID: 30573745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
    Barouch DH; Tomaka FL; Wegmann F; Stieh DJ; Alter G; Robb ML; Michael NL; Peter L; Nkolola JP; Borducchi EN; Chandrashekar A; Jetton D; Stephenson KE; Li W; Korber B; Tomaras GD; Montefiori DC; Gray G; Frahm N; McElrath MJ; Baden L; Johnson J; Hutter J; Swann E; Karita E; Kibuuka H; Mpendo J; Garrett N; Mngadi K; Chinyenze K; Priddy F; Lazarus E; Laher F; Nitayapan S; Pitisuttithum P; Bart S; Campbell T; Feldman R; Lucksinger G; Borremans C; Callewaert K; Roten R; Sadoff J; Scheppler L; Weijtens M; Feddes-de Boer K; van Manen D; Vreugdenhil J; Zahn R; Lavreys L; Nijs S; Tolboom J; Hendriks J; Euler Z; Pau MG; Schuitemaker H
    Lancet; 2018 Jul; 392(10143):232-243. PubMed ID: 30047376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens.
    Jin H; Jiao C; Cao Z; Huang P; Chi H; Bai Y; Liu D; Wang J; Feng N; Li N; Zhao Y; Wang T; Gao Y; Yang S; Xia X; Wang H
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009484. PubMed ID: 34086672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice.
    Scott JM; Lebratti TJ; Richner JM; Jiang X; Fernandez E; Zhao H; Fremont DH; Diamond MS; Shin H
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
    Andersson AC; Ragonnaud E; Seaton KE; Sawant S; Folgori A; Colloca S; Labranche C; Montefiori DC; Tomaras GD; Holst PJ
    Vaccine; 2016 Oct; 34(44):5344-5351. PubMed ID: 27633665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Japanese Encephalitis Virus Vaccination Elicits Cross-Reactive HLA-Class I-Restricted CD8 T Cell Response Against Zika Virus Infection.
    Tarbe M; Dong W; Hu G; Xu Y; Sun J; Grayo S; Chen X; Qin C; Zhao J; Liu L; Li X; Leng Q
    Front Immunol; 2020; 11():577546. PubMed ID: 33101303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Live-Attenuated Zika Virus Vaccine with High Production Capacity Confers Effective Protection in Neonatal Mice.
    Ye X; Liu X; Shu T; Deng W; Liao M; Zheng Y; Zheng X; Zhang X; Li T; Fan W; Qu L; Chen L; Li F; Feng L
    J Virol; 2021 Jun; 95(14):e0038321. PubMed ID: 33910950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.
    Li A; Xue M; Attia Z; Yu J; Lu M; Shan C; Liang X; Gao TZ; Shi PY; Peeples ME; Boyaka PN; Liu SL; Li J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Zika virus DNA vaccines based on NS1 and domain III of E.
    Xiong G; Li Y; Chen F; Xiong X; Wang Q; Zhang L; Dong H; Zhu C; Cui J; He M; Cheng H; Hu A; Cheng C; Pang J; Liu G; Chen H
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109308. PubMed ID: 36274487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.